LRP8 and Alzheimer disease: ASOs are emerging as a promising therapeutic platform for neurodegenerative diseases in humans, and our results suggest that improving ApoER2 exon 19 splicing using ASOs offers a novel treatment approach to protect cognitive function in AD.